Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Psychopharmacology Bulletin VOL 47 No. 3, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Alisa B. Busch - Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing
1
x
$
30.00
Protein Biomarkers in Monocytes and CD4+ Lymphocytes for Predicting Lithium Treatment Response of Bipolar Disorder: a Feasibility Study with Tyramine-Based Signal- Amplified Flow Cytometry
1
x
$
30.00
Effect of Mirtazapine Orally Disintegrating Tablets on Health-Related Quality of Life in Elderly Depressed Patients with Comorbid Medical Disorders: A Pilot Study
1
x
$
30.00
A Randomized, Placebo-Controlled Pilot Study of Quetiapine-XR Monotherapy or Adjunctive Therapy to Antidepressant in Acute Major Depressive Disorder with Current Generalized Anxiety Disorder
1
x
$
30.00
View Cart
Checkout
Home
paul-j-perry
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Paul J. Perry, PhD: Therapeutic Drug Monitoring of Antipsychotics
$
30.00
Add to cart
Details
Ryan M. Carnahan, PharmD: A Critical Appraisal of the Utility of the Serum Anticholinergic Activity Assay in Research and Clinical Practice
$
30.00
Add to cart
Details
Ryan M. Carnahan, PharmD: The Relationship of an Anticholinergic Rating Scale With Serum Anticholinergic Activity in Elderly Nursing Home Residents
$
30.00
Add to cart
Details
Vicki L. Ellingrod, PharmD, BCPP: 5-HT2A Receptor Promoter Polymorphism, -1438G/A and Negative Symptom Response to Olanzapine in Schizophrenia
$
30.00
Add to cart
Details
Page load link
Go to Top
